유한양행우
71,000KRWMarket close of 10/21 (Wed)
Up +0.14%+100KRWMarket close of 10/21 (Wed)
- Open
- 68,500
- High
- 71,800
- Low
- 68,500
- Day range
- Day range low 68,500 high 71,800, open 68,500, close 71,000, previous close 70,900
- Volume
- 0×10K shares
- 86.62 million KRW 1.41× the 20-session average
Market close of 10/21 (Wed)
Where it sits in the 1-year range
25%1-year close range 57,000 to 113,300 won, 25% up from the low
25% of the way up from the lowest close in 1 year (252 sessions) · -37.3% from the high
Usual range
Nothing unusual in the 4 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
- Daily moveusual range+0.14%+0.14%, 0.1× the usual (20-session average ±1.51%)That day +0.14% · usual ±1.51% · large-move threshold ±3.0%
The other 3 are within the usual range
- Trading value1.4×usual range
- EarningsOperating income, 8 quarters
- Data date10/21 (Wed)Market close
See the full check report
Quarterly results · Q2 2026
- Revenue639.5B KRW
- vs. year ago
- +10.4%
- vs. prior quarter
- +21.4%
- Operating income66.9B KRW
- vs. year ago
- +34.1%
- vs. prior quarter
- +658.6%
- Operating margin10.5%
- vs. year ago
- +1.8 pp
- vs. prior quarter
- +8.8 pp
Quarterly operating income trend
Same sector · 제약
Up +0.83%· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +1.5% | Up +1.87% | 166.1B KRW |
| 셀트리온 | Close over the last 20 sessions +9.6% | Up +0.10% | 119.2B KRW |
| 지투지바이오 | Close over the last 20 sessions +27.6% | Up +13.78% | 49.8B KRW |
| 삼익제약 | Close over the last 20 sessions -20.3% | Up +2.58% | 47.2B KRW |
| 한미약품 | Close over the last 20 sessions -26.3% | Up +0.26% | 28.1B KRW |
Other share classes of this company · 유한양행
Schedule
- Q3 report due · 11/16 (Mon) · in 25 days
- Next data 10/23 (Fri) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.